
    
      This is an open label randomized controlled study. The pessary will be offered to those
      patients who have a transvaginal cervical length less than 25 mm before 23 weeks 0 days. The
      control group will receive the current standard of care which includes surveillance of
      cervical length, vaginal progesterone, and emergency cerclage. The primary outcome of the
      study is preterm delivery less than 37 weeks 0 days.
    
  